chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Underdose
Clinical narrative: Booster dose/administered a booster dose for the Moderna COVID-19 vaccine instead of a full primary series dose; Dose 1 was administered on 10-MAR-2022 and Dose 2 on 27-APR-2022; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Booster dose/administered a booster dose for the Moderna COVID-19 vaccine instead of a full primary series dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 10-MAR-2022 and Dose 2 on 27-APR-2022) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch nos. 056M21A and 032M20M) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 27-Apr-2022, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On 27-Apr-2022, the patient experienced UNDERDOSE (Booster dose/administered a booster dose for the Moderna COVID-19 vaccine instead of a full primary series dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 10-MAR-2022 and Dose 2 on 27-APR-2022). At the time of the report, UNDERDOSE (Booster dose/administered a booster dose for the Moderna COVID-19 vaccine instead of a full primary series dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 was administered on 10-MAR-2022 and Dose 2 on 27-APR-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No symptoms were reported after receipt of the Moderna COVID-19 vaccine.   No additional doses, medications, or treatments have been administered.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: tenderness in the left arm; fever of 102 degrees Fahrenheit; "threw up" five times; "really bad" severe headache; nausea; aches, pains; skin hurt; couldn't even walk; like "a Mac Truck hit her", "knocked out", "dead over here"; "wild reaction", "hit so bad"; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION ("wild reaction", "hit so bad"), VACCINATION SITE PAIN (tenderness in the left arm), PYREXIA (fever of 102 degrees Fahrenheit), VOMITING ("threw up" five times) and HEADACHE ("really bad" severe headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 056M21A and 031H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: J&J COVID-19 vaccine (Vaccine administered on  left deltoid) on 29-Mar-2021. Past adverse reactions to the above products included No adverse event with J&J COVID-19 vaccine. Concurrent medical conditions included Penicillin allergy, Penicillin allergy, Drug allergy, Drug allergy, Drug allergy, Drug allergy, Latex allergy, Asthma exercise induced (Started In her late 20's.Patient is doing pretty good.) and Immunocompromised (Patient stated "immune system is not the best.). Concomitant products included SALBUTAMOL SULFATE (INHALERIN) for Exercise induced asthma.   On 15-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 25-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 26-Apr-2022, the patient experienced IMMUNISATION REACTION ("wild reaction", "hit so bad"), HEADACHE ("really bad" severe headache), NAUSEA (nausea), PAIN (aches, pains), PAIN OF SKIN (skin hurt), GAIT INABILITY (couldn't even walk) and FEELING ABNORMAL (like "a Mac Truck hit her", "knocked out", "dead over here"). On 26-Apr-2022 at 1:45 AM, the patient experienced VACCINATION SITE PAIN (tenderness in the left arm), PYREXIA (fever of 102 degrees Fahrenheit) and VOMITING ("threw up" five times). The patient was treated with ACETAMINOPHEN at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, IMMUNISATION REACTION ("wild reaction", "hit so bad") and VOMITING ("threw up" five times) had resolved and VACCINATION SITE PAIN (tenderness in the left arm), PYREXIA (fever of 102 degrees Fahrenheit), HEADACHE ("really bad" severe headache), NAUSEA (nausea), PAIN (aches, pains), PAIN OF SKIN (skin hurt), GAIT INABILITY (couldn't even walk) and FEELING ABNORMAL (like "a Mac Truck hit her", "knocked out", "dead over here") was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test positive: positive (Positive) Positive. Patient Went to Emergency Room for observation. Given IV Fluids..         This case was linked to MOD-2022-552550 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Accidental underdose
Clinical narrative: 1st  Moderna Dose- Patient was given 0.25 mL instead of 0.5 mL; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (1st  Moderna Dose- Patient was given 0.25 mL instead of 0.5 mL) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .25 milliliter. On 31-Mar-2022, the patient experienced ACCIDENTAL UNDERDOSE (1st  Moderna Dose- Patient was given 0.25 mL instead of 0.5 mL). At the time of the report, ACCIDENTAL UNDERDOSE (1st  Moderna Dose- Patient was given 0.25 mL instead of 0.5 mL) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. It was reported that the dose was administered exactly 28 days from today (31Mar2022). No treatment medication was reported.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Blood test, Condition aggravated, SARS-CoV-2 test, Urine analysis
Clinical narrative: Hair loss have worsened after getting the second dose of the vaccine.; Hair loss have worsened after getting the second dose of the vaccine.; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair loss have worsened after getting the second dose of the vaccine.) and CONDITION AGGRAVATED (Hair loss have worsened after getting the second dose of the vaccine.) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041J21A and 032H271A) for COVID-19 vaccination.     The patient's past medical history included Carpal tunnel syndrome (hand surgery of carpal tunnel syndrome. Status has improved after the surgery.) in January 2022 and Surgery (Patient had hand surgery of carpal tunnel syndrome) in January 2022. Concurrent medical conditions included Penicillin allergy (since patient was a kid), Allergy to NSAIDs (Aspirin allergy since patient was a kid) and Heartbeats irregular (Since patient was a kid, Improvement on condition.). Concomitant products included VITAMIN D NOS for Carpal tunnel syndrome, METOPROLOL for Heartbeats irregular.   On 23-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2022, the patient experienced ALOPECIA (Hair loss have worsened after getting the second dose of the vaccine.) and CONDITION AGGRAVATED (Hair loss have worsened after getting the second dose of the vaccine.). At the time of the report, ALOPECIA (Hair loss have worsened after getting the second dose of the vaccine.) and CONDITION AGGRAVATED (Hair loss have worsened after getting the second dose of the vaccine.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) Normal. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative COVID Test prior to hand surgery of carpal tunnel syndrome last January 2022. On an unknown date, Urine analysis: normal (normal) Normal.         Patient received no vaccine 1 month prior to Moderna Covid-19 Vaccine. The Patient experienced hair loss after getting the first dose of vaccine but prior to getting the vaccine the patient does had any hair loss.The Hair loss symptoms were worsened after taking 2nd dose of vaccination since the patient was losing tons of hair every time she used to comb her hair. Patient seek medical help 2 weeks ago. No treatment medication information provided.   This case was linked to MOD-2022-552952 (Patient Link).
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Constipation, Nausea, Pain, Pyrexia
Clinical narrative: accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood; normal aching at the site where it was administered; slowly spread though their body and has stayed with them since the first shot; constipated; nauseous; having occasional fever and chills; having occasional fever and chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (slowly spread though their body and has stayed with them since the first shot), CONSTIPATION (constipated), SKIN LACERATION (accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood), VACCINATION SITE PAIN (normal aching at the site where it was administered) and NAUSEA (nauseous) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced CONSTIPATION (constipated), NAUSEA (nauseous), PYREXIA (having occasional fever and chills) and CHILLS (having occasional fever and chills). On 17-Nov-2021, the patient experienced PAIN (slowly spread though their body and has stayed with them since the first shot) and VACCINATION SITE PAIN (normal aching at the site where it was administered). On an unknown date, the patient experienced SKIN LACERATION (accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood). At the time of the report, PAIN (slowly spread though their body and has stayed with them since the first shot), CONSTIPATION (constipated), VACCINATION SITE PAIN (normal aching at the site where it was administered), NAUSEA (nauseous), PYREXIA (having occasional fever and chills) and CHILLS (having occasional fever and chills) was resolving and SKIN LACERATION (accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  It was reported that, 1-2 weeks later the patient started feeling nauseous, constipated, and had occasional fever and chills. The fever never registered as a temperature, but it felt like they were burning up. This continued and gradually built up until 2 weeks before receiving the second dose of the vaccine when he accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood.   The patient was treated with unspecified supplements and pain killers.   This case was linked to MOD-2022-553156.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Skin laceration, Vaccination site pain
Clinical narrative: accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood; normal aching at the site where it was administered; slowly spread though their body and has stayed with them since the first shot; constipated; nauseous; having occasional fever and chills; having occasional fever and chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (slowly spread though their body and has stayed with them since the first shot), CONSTIPATION (constipated), SKIN LACERATION (accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood), VACCINATION SITE PAIN (normal aching at the site where it was administered) and NAUSEA (nauseous) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced CONSTIPATION (constipated), NAUSEA (nauseous), PYREXIA (having occasional fever and chills) and CHILLS (having occasional fever and chills). On 17-Nov-2021, the patient experienced PAIN (slowly spread though their body and has stayed with them since the first shot) and VACCINATION SITE PAIN (normal aching at the site where it was administered). On an unknown date, the patient experienced SKIN LACERATION (accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood). At the time of the report, PAIN (slowly spread though their body and has stayed with them since the first shot), CONSTIPATION (constipated), VACCINATION SITE PAIN (normal aching at the site where it was administered), NAUSEA (nauseous), PYREXIA (having occasional fever and chills) and CHILLS (having occasional fever and chills) was resolving and SKIN LACERATION (accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  It was reported that, 1-2 weeks later the patient started feeling nauseous, constipated, and had occasional fever and chills. The fever never registered as a temperature, but it felt like they were burning up. This continued and gradually built up until 2 weeks before receiving the second dose of the vaccine when he accidentally cut themselves with a kitchen knife and lost 1.5 pints of blood.   The patient was treated with unspecified supplements and pain killers.   This case was linked to MOD-2022-553156.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered two booster doses after the expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered two booster doses after the expiration date) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022J21A, 053E21A, 038A21A and 022M20A) for COVID-19 vaccination.     It was reported that patient was not diagnosed with/tested positive for COVID-19. It was reported that patient did not have any acute illnesses at time of vaccination.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 04-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 25-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 25-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered two booster doses after the expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered two booster doses after the expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not reported. The vial was initially stored in refrigerator on 18-Apr-2022. The vial did not undergo any temperature excursions. Patient received expired second booster dose. It was stated that no adverse reaction was reported by the patient after receiving the vaccine and after 15 minutes of standard post-vaccination observation.  Treatment information was not provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness
Clinical narrative: Flu like symptoms after first booster; stayed in bed for one and a half days.; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms after first booster) and FATIGUE (stayed in bed for one and a half days.) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A, 014M20A and 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Lumbar disc disease (spinal problem (Spaces between L3 and L4).).   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Nov-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms after first booster) and FATIGUE (stayed in bed for one and a half days.). On 17-Nov-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms after first booster) and FATIGUE (stayed in bed for one and a half days.) had resolved.            It was reported that he receives Steroid injections from time to time for long time medical condition with his spine in the lumbar region.The shots did not make his pre-existing spinal problem worse. After the first dose, he did not have any side effects. Patient does not recall if any side effects after second dose.  No treatment medications were reported.   This case was linked to MOD-2022-553180 (Patient Link).
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient administered booster dose of the Moderna vaccination after the expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patient administered booster dose of the Moderna vaccination after the expiration date) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022J21A, 020B21A, 001C21A and 077C21B) for COVID-19 vaccination.     The patient had never been diagnosed or tested positive for COVID-19. No acute illness reported at the time of vaccination or up to one month before it. Patients chronic and long-standing conditions were reported as unknown. Prescriptions, over-the-counter medications, dietary supplements, or herbal remedies being taken at time of vaccination and/or at the time of the adverse event was reported as unknown.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 25-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 25-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (The patient administered booster dose of the Moderna vaccination after the expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patient administered booster dose of the Moderna vaccination after the expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient had no adverse reaction  after receiving the vaccine and after 15 minutes of standard post-vaccination observation.  The vial was initially stored in refrigerator on 18-Apr-2022. The vial did not undergo any temperature excursion. Number was doses/vials was 2. The frequency was reported as times per.  No treatment medications were reported.   This case was linked to MOD-2022-548520 (Patient Link).
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: administered two booster doses after the expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered two booster doses after the expiration date) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022J21A, 041C21A, 028L20A and 039K20-2A) for COVID-19 vaccination.     The patient had not tested/diagnosed with COVID-19. The patient had no acute illnesses at the time of vaccination and up to one month before. It was unknown if patient had chronic or long-standing health conditions and it was unknown if the patient had prescriptions, over-the-counter medications, dietary supplements, or herbal remedies being taken at time of vaccination. The details of allergies to medications, food, and other products were not reported.    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 25-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 25-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered two booster doses after the expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered two booster doses after the expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient had no adverse reaction  after receiving the vaccine and after 15 minutes of standard post-vaccination observation.  The vial was initially stored in refrigerator on 18-Apr-2022. The vial did not undergo any temperature excursion. Number was doses/vials was 2. The frequency was reported as times per.  No treatment medications were reported.   This case was linked to MOD-2022-548520.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patients received expired Moderna COVID-19 vaccine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-Apr-2022 and was forwarded to Moderna on 28-Apr-2022.    This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received expired Moderna COVID-19 vaccine) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received expired Moderna COVID-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received expired Moderna COVID-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.  The vials were initially stored in refrigerator on 04-Apr-2022. The vial has not undergone temperature excursion.  It was reported that the pharmacist thought that the expiry date of the vaccine was Jun-2022, However the vaccine expired on 01-Apr-2022.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired on 01 Apr 2022 and was administered on 02 Apr 2022.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01 Apr 2022 and was administered on 02 Apr 2022.) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01 Apr 2022 and was administered on 02 Apr 2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01 Apr 2022 and was administered on 02 Apr 2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. It was reported thought that the vaccine expired in Jun-2022, however it was expired on 01-Apr-2022. Date the vial was initially stored in refrigerator was 04 Apr 2022. Vial had not undergone any temperature excursion. No treatment information was reported.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine was expired on 01 Apr 2022 and was administered on 02 Apr 2022.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01 Apr 2022 and was administered on 02 Apr 2022.) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.  No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01 Apr 2022 and was administered on 02 Apr 2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01 Apr 2022 and was administered on 02 Apr 2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. It was reported that the pharmacist thought the vaccine expiry would be in Jun-2022, however it expired on 01-Apr-2022. The  date the vial was initially stored in refrigerator was 04 Apr 2022. The vial did not undergo any temperature excursion. Treatment information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: patients were vaccinated with expired doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients were vaccinated with expired doses) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients were vaccinated with expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients were vaccinated with expired doses) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo any temperature excursions. It was reported that pharmacist thought that the vaccine was expired in Jun-2022, however it was expired on 01-Apr-2022.  No treatment information was reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to patient) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial did not undergo any temperature excursions.  No treatment medication was reported.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccinated with expired Moderna dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated with expired Moderna dose) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated with expired Moderna dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccinated with expired Moderna dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  The pharmacist was called to verify an expiration date for Lot 026L21B, the pharmacist says that he thought that the vaccine expired in June 2022, however the vaccine expired on 01-Apr-2022, and 80 patients received the expired vaccine.   Vial was initially stored in refrigerator on 04-Apr-2022. Vial undergo no temperature excursions.  No treatment drug was reported.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022; Patient received expired Moderna COVID-19 Vccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was reported.  The vials were initially stored in refrigerator on 04-Apr-2022. The vial has not undergone temperature excursion. It was reported that the pharmacist thought that the expiry date of the vaccine was Jun-2022, however the vaccine expired on 01-Apr-2022. No treatment medication information was given.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received expired Moderna COVID-19 Vccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Moderna COVID-19 Vccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.  The vials were initially stored in refrigerator on 04-Apr-2022. The vial has not undergone temperature excursion.  It was reported that the pharmacist thought that the expiry date of the vaccine was Jun-2022, However the vaccine expired on 01-Apr-2022.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered to 155 patients; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. The vial was initially stored in refrigerator on 04-PAR-2022. The vial did not undergo any temperature excursion. The pharmacist says that pharmacist thought that the vaccine expired in June 2022 however the vaccine expired on 01-APR-2022. No treatment details were provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was expired on 01-Apr-2022, vial was initially stored in refrigerator on 04-Apr-2022 and was administered on 05-Apr-2022; Vaccine was expired on 01-Apr-2022 and was administered on 05-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, vial was initially stored in refrigerator on 04-Apr-2022 and was administered on 05-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 and was administered on 05-Apr-2022) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination. No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 and was administered on 05-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, vial was initially stored in refrigerator on 04-Apr-2022 and was administered on 05-Apr-2022). At the time of the report, PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, vial was initially stored in refrigerator on 04-Apr-2022 and was administered on 05-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 and was administered on 05-Apr-2022) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported thought that the vaccine expired in Jun-2022, however it was expired on 01-Apr-2022. Date the vial was initially stored in refrigerator on 04-Apr-2022. Vial had not undergone any temperature excursion. No treatment medications were reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Expired vaccine administered to 155 patients/ 80 Patients received expired moderna COVID-19 vaccine; Vaccine expired on 01-Apr-2022 and date moved to refrigeration on 04-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients/ 80 Patients received expired moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022 and date moved to refrigeration on 04-Apr-2022) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients/ 80 Patients received expired moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022 and date moved to refrigeration on 04-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to 155 patients/ 80 Patients received expired moderna COVID-19 vaccine) and PRODUCT STORAGE ERROR (Vaccine expired on 01-Apr-2022 and date moved to refrigeration on 04-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. It was reported that pharmacist thought the vaccine expiry was on Jun 2022, however vaccine expired on 01 Apr 2022. Date the vial was initially stored in refrigerator was found to be 04 Apr 2022. Vial did not undergone any temperature excursion. No treatment medications were provided.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered to the patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to the patient) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to the patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered to the patient) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo any temperature excursions. It was reported that pharmacist thought that the vaccine expired in Jun-2022, however it was expired on 01-Apr-2022.  No treatment information was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022; Expired vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 04-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  It was reported that, when the vaccine lot received to pharmacy on 23-Feb-2022, the pharmacy staff member looked up the expiration date and came up with expiry date of June 2022. However the correct expiry date for lot was 01-Apr-2022.  The vial did not undergo any temperature excursions.  No treatment medication was reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the vial was initially stored in the refrigerator on 04-Apr-2022. It was reported that the vial had not underwent any temperature excursion.  No treatment medications were reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Patient received vaccine on 5apr2022 which was expired on 01Apr2022 and vaccine was stored in refrigerator on 04apr2022; Patient received vaccine on 5apr2022 which was expired on 01Apr2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 5apr2022 which was expired on 01Apr2022) and PRODUCT STORAGE ERROR (Patient received vaccine on 5apr2022 which was expired on 01Apr2022 and vaccine was stored in refrigerator on 04apr2022) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 5apr2022 which was expired on 01Apr2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received vaccine on 5apr2022 which was expired on 01Apr2022 and vaccine was stored in refrigerator on 04apr2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 5apr2022 which was expired on 01Apr2022) and PRODUCT STORAGE ERROR (Patient received vaccine on 5apr2022 which was expired on 01Apr2022 and vaccine was stored in refrigerator on 04apr2022) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  Reporter stated that dose was administered after 30 day use by date or after manufacturer date of expiry.  Date the vial was initially stored in the refrigerator was 04APR2022. The vial didnot undergone any temperature excursion.  No treatment medications were reported.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine on 02-Apr-2022, post expiry date of 01-Apr-2022.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 02-Apr-2022, post expiry date of 01-Apr-2022.) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 02-Apr-2022, post expiry date of 01-Apr-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine on 02-Apr-2022, post expiry date of 01-Apr-2022.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter.  The vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo any temperature excursions. It was reported that pharmacist thought that the vaccine expired in Jun-2022, however it was expired on 01-Apr-2022.  Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The pharmacist thought that vaccine will expired on Jun-2022, however vaccine was expired on 01-Apr-2022.  The frequency was reported as times per. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2022: Follow-up document received on 29-Apr-2022 included no new information.